The following 2020 ASCIA Action Plans are the latest versions. However, the 2018 and 2017 versions of ASCIA Action Plans are still valid for use throughout 2020 and 2021, or until the due date for review stated on the plan.
For information about recent changes to ASCIA Action Plans go to www.allergy.org.au/hp/anaphylaxis/action-plans-for-allergic-reactions-faq
This plan is provided to people with allergies who have been prescribed EpiPen® adrenaline autoinjectors.
This plan is provided to people with allergies who have been prescribed any brand of adrenaline autoinjectors.
This plan is provided to people with allergies who have not been prescribed adrenaline autoinjector/s.
An ASCIA Action Plan for Anaphylaxis for use with adrenaline autoinjectors on airlines is available upon request. This plan is should be stored with adrenaline autoinjectors in emergency medical kits on airlines.
Note: These have replaced the general versions of ASCIA Action Plans for Anaphylaxis (ORANGE)
This plan can be used as a poster or stored with general use EpiPen® adrenaline autoinjectors.
This plan can be used as a poster or stored with general use adrenaline autoinjectors.
For translated versions of ASCIA First Aid for Anaphylaxis go to www.allergy.org.au/hp/anaphylaxis#ta5
For further information about ASCIA Action Plans and other anaphylaxis resources go to www.allergy.org.au/anaphylaxis
1. ASCIA Action Plans should be reviewed and reissued when patients are reassessed by their doctor or nurse practitioner, and each time they obtain a new adrenaline autoinjector prescription, which is approximately every 12 to 18 months. If there are no changes in diagnosis or management the medical information on the ASCIA Action Plan may not need to be updated. However, if the patient is a child, the photo should be updated each time, so they can be easily identified.
2. ASCIA Action Plans for Anaphylaxis can be used for people with food, insect, tick and drug allergies, or any other allergy that can result in a severe allergic reaction (anaphylaxis).
3. Adrenaline autoinjectors contain a single, fixed dose of adrenaline and are designed to be used by anyone (medical training is not required), including friends, teacher, childcare worker, parents or patients (if they are not too unwell or too young).
4. It is generally recommended that people who have an adrenaline autoinjector should also wear a medical identification/emergency response emblem or other medical identification.
5. ASCIA Action Plans should be used as part of a comprehensive anaphylaxis management plan that includes:
Content updated April 2020
Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:
ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases